Impaired baroreflex function in mice overexpressing alpha-synuclein

Frontiers in Neurology

Volumn 4 JUL, Issue , 2013, Pages

  Fleming, Sheila M ^a,b   Jordan, Maria C ^c   Mulligan, Caitlin K ^c   Masliah, Eliezer ^d   Holden, John G ^a   Millard, Ronald W ^a   Chesselet, Marie Françoise ^c   Roos, Kenneth P ^c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alpha synuclein; Baroreflex; Mouse model; Orthostatic hypotension; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; ATROPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; HEART RATE; HEMODYNAMICS; HYPERTENSION; HYPOTENSION; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PARKINSON DISEASE; PRESSORECEPTOR REFLEX; PROTEIN EXPRESSION; SYNUCLEINOPATHY; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TELEMETRY; WILD TYPE;

EID: 84883533766     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00103     Document Type: Article

References (43)

1. Szili-Török T, Kálmán J, Paprika D, Dibó G, Rózsa Z, Rudas L. Depressed baroreflex sensitivity in patients with Alzheimer's and Parkinson's disease. Neurobiol Aging (2001) 22:435-8. doi:10.1016/S0197-4580(01)00210-X
2. Goldstein DS. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol (2003) 2:669-76. doi:10.1016/S1474-4422(03)00555-6
3. Kaufmann H, Nahm K, Purohit D, Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology (2004) 63:1093-5. doi:10.1212/01.WNL.0000138500.73671.DC
4. Goldstein DS. Orthostatic hypotension as an early finding in Parkinson's disease. Clin Auton Res (2006) 16:46-54. doi:10.1007/s10286-006-0317-8
5. Barbic F, Perego F, Canesi M, Gianni M, Biagiotti S, Costantino G, et al. Early abnormalities of vascular and cardiac autonomic control in Parkinson's disease without orthostatic hypotension. Hypertension (2007) 49:120-6. doi:10.1161/01.HYP.0000250939.71343.7c
6. Goldstein DS, Sharabi Y, Karp BI, Bentho O, Saleem A, Pacak K, et al. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Cleve Clin J Med (2009) 76(Suppl 2):S47-50. doi:10.3949/ccjm.76.s2.10
7. Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, et al. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. Mov Disord (2010) 25(14):2296-303. doi:10.1002/mds.23348
8. Lu SF, Young HJ, Lin MT. Nigrostriatal dopamine system mediates baroreflex sensitivity in rats. Neurosci Lett (1995) 190:17-20. doi:10.1016/0304-3940(95)11489-J
9. Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med (2000) 41:71-7.
10. Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM, et al. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet (2010) 19(9):1633-50. doi:10.1093/hmg/ddq038
11. Griffioen KJ, Rothman SM, Ladenheim B, Wan R, Vranis N, Hutchison E, et al. Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein. Neurobiol Aging (2013) 34:928-35. doi:10.1016/j.neurobiolaging.2012.07.008
12. Forno LS, Norville RL. Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol (1976) 34:183-97. doi:10.1007/BF00688674
13. Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, et al. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology (1999) 52:1269-71. doi:10.1212/WNL.52.6.1269
14. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2003) 24:197-211. doi:10.1016/S0197-4580(02)00065-9
15. Singleton A, Gwinn-Hardy K, Sharabi Y, Li ST, Holmes C, Dendi R, et al. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain (2004) 127:768-72. doi:10.1093/brain/awh081
16. Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, et al. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res (2002) 68:568-78. doi:10.1002/jnr.10231
17. Fernagut PO, Hutson CB, Fleming SM, Tetreaut NA, Salcedo J, Masliah E, et al. Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression. Synapse (2007) 61:991-1001. doi:10.1002/syn.20456
18. Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, Chesselet MF. Olfactory dysfunction in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci (2008) 28:247-56. doi:10.1111/j.1460-9568.2008.06346.x
19. Wang L, Fleming SM, Chesselet M-F, and Taché Y.. Abnormal colonic motility in mice overexpressing human wildtype alpha-synuclein. Neuroreport (2008) 19:873-6. doi:10.1097/WNR.0b013e3282ffda5e
20. Wang L, Magen I, Yuan PQ, Subramaniam SR, Richter F, Chesselet MF, et al. Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation. Neurogastroenterol Motil (2012) 24(9):e425-36. doi:10.1111/j.1365-2982.2012.01974.x
21. Magen I, Fleming SM, Zhu C, Garcia EC, Cardiff KM, Dinh D, et al. Cognitive deficits in a mouse model of pre-manifest Parkinson's disease. Eur J Neurosci (2012) 35(6):870-82. doi:10.1111/j.1460-9568.2012.08012.x
22. Hallett PJ, McLean JR, Kartunen A, Langston JW, Isacson O. Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits. Neurobiol Dis (2012) 47(2):258-67. doi:10.1016/j.nbd.2012.04.009
23. Lam HA, Wu N, Cely I, Kelly RL, Hean S, Richter F, et al. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein. J Neurosci Res (2011) 89:1091-102. doi:10.1002/jnr.22611
24. Fleming SM, Salcedo J, Hutson CB, Rockenstein E, Masliah E, Levine MS, et al. Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synuclein. Neuroscience (2006) 142:1245-53. doi:10.1016/j.neuroscience.2006.07.005
25. Fleming SM, Mulligan CK, Richter F, Mortazavi F, Lemesre V, Frias C, et al. A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions. Mol Cell Neurosci (2011) 46(3):597-606. doi:10.1016/j.mcn.2010.12.011
26. Shai SY, Harpf AE, Babbitt CJ, Jordan MC, Fishbein MC, Chen J, et al. Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res (2002) 90:458-64. doi:10.1161/hh0402.105790
27. Holschneider DP, Scremin OU, Roos KP, Chialvo DR, Chen K, Shih JC. Increased baroreceptor response in mice deficient in monoamine oxidase A and B. Am J Physiol Heart Circ Physiol (2002) 282:H964-72.
28. Jordan MC, Henderson SA, Han T, Fishbein MC, Philipson KD, Roos KP. Myocardial function with reduced expression of the sodium-calcium exchanger. J Card Fail (2010) 16(9):786-96. doi:10.1016/j.cardfail.2010.03.012
29. Schroeder AM, Loh DH, Jordan MC, Roos KP, Colwell CS. Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington's disease. PLoS Curr (2011) 3::RRN1266. doi:10.1371/currents.RRN1266
30. Jordan MC, Zheng Y, Ryazantsev S, Rozengurt N, Roos KP, Neufeld EF. Cardiac manifestations in the mouse model of mucopolysaccharidosis I. Mol Genet Metab (2005) 86:233-43. doi:10.1016/j.ymgme.2005.05.003
31. Bissonnette JM, Knopp SJ, Maylie J, Thong T. Autonomic cardiovascular control in methyl-CpG-binding protein 2 (Mecp2) deficient mice. Auton Neurosci (2007) 136(1-2):82-9. doi:10.1016/j.autneu.2007.04.007
32. Gehrmann J, Hammer PE, Maguire CT, Wakimoto H, Triedman JK, Berul CI. Phenotypic screening for heart rate variability in the mouse. Am J Physiol Heart Circ Physiol (2000) 279(2):H733-40.
33. Kakiya S, Arima H, Yokoi H, Murase T, Yambe Y, Oiso Y. Effects of acute hypotensive stimuli on arginine vasopressin gene transcription in the rat hypothalamus. Am J Physiol Endocrinol Metab (2000) 279(4):E886-92.
34. Parati G, Di Rienzo M, Mancia G. Dynamic modulation of baroreflex sensitivity in health and disease. Ann N Y Acad Sci (2001) 940:469-87. doi:10.1111/j.1749-6632.2001.tb03699.x
35. Monahan KD. Effect of aging on baroreflex function in humans. Am J Physiol Regul Integr Comp Physiol (2007) 293(1):R3-12. doi:10.1152/ajpregu.00031.2007
36. Goldstein DS, Eldadah BA, Holmes C, Pechnik S, Moak J, Saleem A, et al. Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension (2005) 46(6):1333-9. doi:10.1161/01.HYP.0000188052.69549.e4
37. Idiaquez J, Benarroch EE, Rosales H, Milla P, and Ríos L. Autonomic and cognitive dysfunction in Parkinson's disease. Clin Auton Res (2007) 17:93-8. doi:10.1007/s10286-007-0410-7
38. Jain S, Goldstein DS. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis (2012) 46(3):572-80. doi:10.1016/j.nbd.2011.10.025
39. Nakamura T, Hirayama M, Ito H, Takamori M, Hamada K, Takeuchi S, et al. Dobutamine stress test unmasks cardiac sympathetic denervation in Parkinson's disease. J Neurol Sci (2007) 263(1-2):133-8. doi:10.1016/j.jns.2007.07.005
40. Buob A, Winter H, Kindermann M, Becker G, Möller JC, Oertel WH, et al. Parasympathetic but not sympathetic cardiac dysfunction at early stages of Parkinson's disease. Clin Res Cardiol (2010) 99:701-6. doi:10.1007/s00392-010-0170-6
41. Goldstein DS, Sharabi Y, Karp BI, Bentho O, Saleem A, Pacak K, et al. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Clin Auton Res (2007) 17(2):118-21. doi:10.1007/s10286-007-0396-1
42. Fleming SM, Jentsch JD, Chesselet M-F. Cognitive dysfunction in genetic mouse models of parkinsonism. In: D Van Dam editor. Neuromethods: Animal Models of Dementia. New York, NY: Springer-Humana Press (2011). p. 485-92.
43. Curtis AL, Drolet G, Valentino RJ. Hemodynamic stress activates locus coeruleus neurons of unanesthetized rats. Brain Res Bull (1993) 31:737-44. doi:10.1016/0361-9230(93)90150-A